TFIID Inhibitors

Common TFIID Inhibitors include, but are not limited to Triptolide CAS 38748-32-2, Actinomycin D CAS 50-76-0, α-Amanitin CAS 23109-05-9, DRB CAS 53-85-0 and ICRF-193 CAS 21416-68-2.

TFIID is a complex multimeric protein assembly that plays a fundamental role in the process of eukaryotic transcription initiation. It is a critical component of the RNA polymerase II pre-initiation complex (PIC), which assembles at the promoter regions of protein-coding genes. TFIID is composed of the TATA-binding protein (TBP) and multiple TBP-associated factors (TAFs). The TBP subunit of TFIID recognizes and binds to the TATA-box, a specific DNA sequence often found in the promoter regions of genes. Meanwhile, the TAFs contribute to the recognition of other promoter elements and help recruit additional transcription factors and RNA polymerase II to the promoter. The proper assembly and function of the TFIID complex are crucial for the precise regulation of gene expression.

TFIID inhibitors are molecules that interfere with the function or assembly of the TFIID complex. These inhibitors can act by various mechanisms. Some may bind directly to TFIID components, preventing their proper interaction with DNA or other transcriptional machinery components. Others may hinder the assembly of the TFIID complex by blocking the interaction between TBP and TAFs. Additionally, certain TFIID inhibitors might alter the conformation of the complex, rendering it non-functional. By targeting TFIID, these inhibitors can exert a profound effect on the transcriptional landscape of the cell, as the initiation of transcription by RNA polymerase II is a foundational step in gene expression. The development and study of TFIID inhibitors provide valuable tools for dissecting the intricacies of transcriptional regulation and understanding the fundamental biology of the cell.